Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Low-level laser therapy combined with Neoptide improved hair regrowth better than either treatment alone in rats.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

Hair follicle bulge cells don't help skin regrow after glucocorticoid damage; interfollicular epidermis cells do.